CD4 and tuberculosis: The available studies in Nigeria were conducted on TB/HIV patients managed during the early periods of TB/HIV collaborative activities when they are eligible for commencement of antiretroviral therapy (ART) within two months of TB treatment only if their CD4+ count fell below 200 cells/mL [8, 20–23], and HIV-infected TB patients were treated for TB at the TB clinics.